1-6 of 6
Holly Trautman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Assessing the Need for a Biosimilar: A Systematic Literature Review of the Treatment Burden of Rituximab in Hematological Malignancies

Elizabeth James, Holly Trautman, Gerard Hoehn, PhD, Erika Szabo, Boxiong Tang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5908.
https://doi.org/10.1182/blood-2018-99-110953
Published: 2018
Journal Articles

Comparative Cost-Efficiency Analysis of Granulocyte Colony-Stimulating Factors for Use in Chemotherapy Patients in the United States

Elizabeth James, Holly Trautman, Erika Szabo, Boxiong Tang, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4667.
https://doi.org/10.1182/blood.V130.Suppl_1.4667.4667
Published: 2017
Journal Articles

Budget Impact Analysis of Switching Chemotherapy Patients Using Granulocyte Colony-Stimulating Factors (G-CSFs) from Pegfilgrastim to Short-Acting G-CSFs in the United States

Elizabeth James, Holly Trautman, Erika Szabo, Boxiong Tang, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4668.
https://doi.org/10.1182/blood.V130.Suppl_1.4668.4668
Published: 2017
Journal Articles

Budget Impact Analysis of Treating Chemotherapy Patients with Patient-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Holly Trautman, Erika Szabo, Francesco Lo-Coco, Elizabeth James, Susan Gabriel, Jifang Zhou, Ashutosh Pathak, Boxiong Tang
Journal: Blood
Blood (2016) 128 (22): 4786.
https://doi.org/10.1182/blood.V128.22.4786.4786
Published: 2016
Journal Articles

Budget Impact Analysis of Treating Chemotherapy Patients with Health Care Provider-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Holly Trautman, Erika Szabo, Francesco Lo-Coco, Elizabeth James, Susan Gabriel, Jifang Zhou, Ashutosh Pathak, Boxiong Tang
Journal: Blood
Blood (2016) 128 (22): 2407.
https://doi.org/10.1182/blood.V128.22.2407.2407
Published: 2016
Journal Articles

A Budget Impact Model Comparing Resource Utilization of Four Approved Therapies for Multiple Myeloma (MM) in the US.

D.S. Pete Fullerton, Holly Trautman, Hui Huang, Jelena Veljkovic, Dixie-Lee Esseltine, Jing Marantz
Journal: Blood
Blood (2007) 110 (11): 3324.
https://doi.org/10.1182/blood.V110.11.3324.3324
Published: 2007